Literature DB >> 33609201

Cytokines associated with hemorrhage in proliferative diabetic retinopathy.

Ho Ra1, Anna Lee1, Junhyuck Lee1, Inkee Kim1, Jiwon Baek2.   

Abstract

PURPOSE: To investigate aqueous cytokine levels in association with hemorrhage in proliferative diabetic retinopathy (PDR) in patients with type 2 diabetes mellitus.
METHODS: Sixty-six eyes with treatment-naïve PDR, including 26 hemorrhagic and 40 nonhemorrhagic eyes were included in this institutional study. Aqueous humor levels of interleukin (IL)-1b, IL-6, IL-8, IL-10, monocyte chemoattractant protein (MCP)-1, tumor necrosis factor (TNF)-α, vascular endothelial growth factor (VEGF), and soluble VEGF receptor-1 were obtained by multiplex bead assay. Visual acuity and hemorrhage area measurements were obtained, and correlations between cytokine levels and hemorrhage were identified.
RESULTS: Levels of MCP-1, TNF-α, and VEGF were higher in hemorrhagic eyes (1506.77 vs. 2131.31 pg/mL, 0.43 vs. 0.63 pg/mL, and 103.96 vs. 206.96 pg/mL; P = 0.050, 0.022, and 0.027, respectively). The levels of IL-8, MCP-1, TNF-α, and VEGF showed positive correlation with visual acuity (P = 0.019, 0.015, 0.001, and 0.014, respectively). The hemorrhage area revealed positive correlation with TNF-α and VEGF levels (P = 0.001 and < 0.001, respectively).
CONCLUSION: The presence and amount of hemorrhage in PDR were associated not only with VEGF concentration, but also with the levels of certain inflammatory cytokines, suggesting a role of both VEGF and inflammation in hemorrhagic eyes.

Entities:  

Keywords:  Hemorrhage; MCP-1; Proliferative diabetic retinopathy (PDR); TNF-a; VEGF

Mesh:

Substances:

Year:  2021        PMID: 33609201     DOI: 10.1007/s10792-021-01746-9

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  26 in total

Review 1.  Diabetic retinopathy.

Authors:  Donald S Fong; Lloyd P Aiello; Frederick L Ferris; Ronald Klein
Journal:  Diabetes Care       Date:  2004-10       Impact factor: 19.112

2.  Vitreous contraction in proliferative diabetic retinopathy.

Authors:  M D Davis
Journal:  Arch Ophthalmol       Date:  1965-12

3.  Natural history of vitreous hemorrhage in diabetic retinopathy.

Authors:  M C Ziemianski; J W McMeel; E P Franks
Journal:  Ophthalmology       Date:  1980-04       Impact factor: 12.079

Review 4.  Pathogenesis and classification of proliferative diabetic vitreoretinopathy.

Authors:  Peter Kroll; Eduardo Büchele Rodrigues; Steffen Hoerle
Journal:  Ophthalmologica       Date:  2007       Impact factor: 3.250

5.  Profile of intraocular tumour necrosis factor-α and interleukin-6 in diabetic subjects with different degrees of diabetic retinopathy.

Authors:  Carin Gustavsson; Carl-David Agardh; Elisabet Agardh
Journal:  Acta Ophthalmol       Date:  2012-04-20       Impact factor: 3.761

6.  Changes in aqueous concentrations of various cytokines after intravitreal triamcinolone versus bevacizumab for diabetic macular edema.

Authors:  Hee Jin Sohn; Dae Heon Han; Im Tae Kim; In Kyung Oh; Kyun Hyung Kim; Dae Yeong Lee; Dong Heun Nam
Journal:  Am J Ophthalmol       Date:  2011-07-22       Impact factor: 5.258

Review 7.  Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy.

Authors:  Rafael Simó; Esther Carrasco; Marta García-Ramírez; Cristina Hernández
Journal:  Curr Diabetes Rev       Date:  2006-02

8.  Association of vitreous inflammatory factors with diabetic macular edema.

Authors:  Hideharu Funatsu; Hidetaka Noma; Tatsuya Mimura; Shuichiro Eguchi; Sadao Hori
Journal:  Ophthalmology       Date:  2009-01       Impact factor: 12.079

9.  Levels of Inflammatory Cytokines IL-1β, IL-6, IL-8, IL-17A, and TNF-α in Aqueous Humour of Patients with Diabetic Retinopathy.

Authors:  Songfu Feng; Honghua Yu; Ying Yu; Yu Geng; Dongli Li; Chun Yang; Qingjun Lv; Li Lu; Ting Liu; Guodong Li; Ling Yuan
Journal:  J Diabetes Res       Date:  2018-04-04       Impact factor: 4.011

10.  Study of 27 aqueous humor cytokines in patients with type 2 diabetes with or without retinopathy.

Authors:  Ning Dong; Bing Xu; Bingsong Wang; Liqun Chu
Journal:  Mol Vis       Date:  2013-08-04       Impact factor: 2.367

View more
  1 in total

1.  Optimal timing of preoperative intravitreal anti-VEGF injection for proliferative diabetic retinopathy patients.

Authors:  Yue Xu; Chi Xie; Yan Fang; Yan Yu; Cui Qiu
Journal:  Int J Ophthalmol       Date:  2022-10-18       Impact factor: 1.645

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.